Tag: LDL


  • CRISPR Gene-Editing Shows Promise in Lowering Cholesterol in Early Study

    CRISPR Gene-Editing Shows Promise in Lowering Cholesterol in Early Study

    New CRISPR-based therapy reduces cholesterol in a small early study A recent small-stage study has sparked cautious optimism in the fight against high cholesterol. Researchers tested an experimental gene-editing therapy delivered by a single infusion to participants with elevated cholesterol levels. The approach uses CRISPR gene editing to target and alter the body’s pathways that…

  • CRISPR Breakthrough: Gene-Editing Drug Lowers High Cholesterol in Early Trial

    CRISPR Breakthrough: Gene-Editing Drug Lowers High Cholesterol in Early Trial

    New Hope for High Cholesterol: A First Look at a CRISPR-Based Therapy In a small, early-stage study, researchers tested an experimental gene-editing drug designed to lower levels of LDL cholesterol, the type often linked to heart disease. The trial involved 15 volunteers who received a single infusion. While the study is preliminary, the findings suggest…

  • How I lowered my cholesterol in four weeks without statins

    How I lowered my cholesterol in four weeks without statins

    My high cholesterol story At 37, I faced a reality many people don’t talk about openly: my cholesterol was higher than it should be. The goal wasn’t just to feel better in the short term but to reduce long‑term heart disease risk. After discussing my results with a medical professional, I decided to pursue a…

  • World-first LAF assay reveals hidden interactions in blood

    World-first LAF assay reveals hidden interactions in blood

    World-first LAF assay: a new lens on blood chemistry A team at the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) has unveiled a world-first assay that rapidly measures interactions between nanoscale particles in the bloodstream. The lipoprotein association fluorometry (LAF) technique can deliver results in about one hour, a dramatic improvement over…

  • World-first LAF Assay Reveals Hidden Blood Interactions in Cancer

    World-first LAF Assay Reveals Hidden Blood Interactions in Cancer

    World-first LAF assay accelerates cancer research A groundbreaking technique developed at the Australian Institute for Bioengineering and Nanotechnology (AIBN) is redefining how scientists study the bloodstream’s tiniest particles. Lipoprotein Association Fluorometry (LAF) is a world-first assay that can rapidly measure interactions between extracellular vesicles (EVs) and lipoproteins—crucial steps in understanding how cancers develop, spread, and…